Is Australia and New Zealand Banking Group a buy at this share price?

The Australia and New Zealand Banking Group (ASX:ANZ) share price has fallen almost 4% year-to-date. Does this put it in the buy zone?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shareholders of Australia's big four banks have had a disappointing start to 2017. So far this year all four have underperformed the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) and its year-to-date decline of around 0.8%.

The worst performer of the group has been Australia and New Zealand Banking Group (ASX: ANZ) with a decline of almost 4%. Does this drop put the banking giant's shares in the buy zone?

Unfortunately I don't think it does. Over the last 12 months I have been bullish on ANZ, but at today's share price I see far more downside risk than upside potential.

At present its shares are changing hands at 15x trailing earnings and 1.5x book value. Whilst this may appear cheap relative to the rest of the market, for the banking sector this is relatively expensive.

Currently the sector average is approximately 14x earnings and 1.3x book value.

Furthermore, in the last 10 years ANZ's shares have traded at an average of 12.5x earnings according to data provided by CommSec. Well below where it trades today.

During the same period Westpac Banking Corp (ASX: WBC) and National Australia Bank Ltd. (ASX: NAB) shares traded at an average of 13x earnings, with Commonwealth Bank of Australia (ASX: CBA) shares commanding an average multiple of 13.5x earnings.

Whilst ANZ's underlying business seems to be performing well and the offloading of non-core assets appears to be an astute move, I couldn't justify an investment today strictly on valuation grounds.

If the share price were to fall to around the $25 to $26 mark, I would snap up its shares in a heartbeat. But until that happens I believe there are far better opportunities out there for investors to take advantage of.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »